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Bone is a metabolically active tissue that undergoes contin-
uous remodeling by two sequential events, bone formation
and resorption. These events are strongly linked and tightly
regulated to maintain skeletal homeostasis. The bone cells
responsible for the dual events include the bone-resorbing
cells, the osteoclasts, arising from monocyte-macrophage
precursors, and the bone forming cells, the osteoblasts,
having a mesenchymal origin. Immune and bone cell activ-
ities are linked by several pathways [1] and the former can
promote bone building or destruction. Further, immune cells
can be involved in the mineralization process occurring in
extra-skeletal sites. In this special issue different authors
highlighted these items both through research articles and
reviews.
In detail, interaction between osteoblast precursors, the
mesenchymal stemcells (MSCs) [2], and immune cells during
fracture repair acts as one of the key factors governing
successful bone healing. Additionally, bone damage following
immune deregulation may be local as in arthritis and peri-
odontal disease (PD) or systemic as in osteoporosis [3] and
osteotropic cancers [4, 5]. It could be multifactorial and thus
due to genetic modifications (i.e., Gaucher disease) as well
as to lipopolysaccharide- (LPS-) mediated release of inflam-
matory cytokines (i.e., PD, osteomyelitis, and arthritis), and
so forth. New insights suggest that, in immune-mediated
bone diseases, bone resorption active phases are character-
ized by increased levels of immunoreceptor tyrosine-based
activation motifs (ITAMs); these molecules together with
OSCAR could be indicative of disease progression. Fur-
ther, osteotropic cancer-related immune alterations showed
distinct immune cell phenotype as observed in chronic
myeloid leukemia, multiple myeloma, and bone metastatic
solid tumors.
State-of-the-art and newmechanisms are clearly described
in this special issue; they can be useful for the identification
of new therapeutic targets and bone disease markers.
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